Patents in the Therapeutic Recombinant Protein Production Using Mammalian Cells

ISSN: 2212-4012 (Online)
ISSN: 1872-2083 (Print)

Volume 9, 3 Issues, 2015

Download PDF Flyer

Recent Patents on Biotechnology

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Rongling Wu
Departments of Public Health Sciences and Statistics
Pennsylvania State College of Medicine
Hershey, PA

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Patents in the Therapeutic Recombinant Protein Production Using Mammalian Cells

Author(s): Virgínia Picanço-Castro, Marcela Cristina Corrêa de Freitas, Aline de Sousa Bomfim and Elisa Maria de Sousa Russo

Affiliation: Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brasil


The industrial production of recombinant proteins requires, preferentially, the generation of stable cell lines expressing proteins in a quickly and reproducibly manner as well as with relative ease. Different methods are used to insert an exogenous DNA into the host cell and the choice of the producing cell is of paramount importance for the efficient production and quality of the recombinant protein. This review addresses the advances in recombinant proteins production in mammalian cell lines, according to the key patents in the last 20 years

Keywords: Recombinant protein, mammalian expression system, patents in biopharmaceuticals

Purchase Online Order Reprints Order Eprints Rights and Permissions


Article Details

Volume: 7
First Page: 1
Last Page: 7
Page Count: 7
DOI: 10.2174/1872208307666131202191925

Related Journals

Webmaster Contact: Copyright © 2015 Bentham Science